Clinical Trial Update: Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating uptake of indocyanine green fluorescence in human carotid artery plaque to assess imaging of atherosclerotic disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Stenosis

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Atherosclerosis, Atherosclerotic Plaque | Phase 1 | Status: COMPLETED